Short Courses*

MONDAY, AUGUST 24 | 12:00 – 3:00 PM

SC1: The Making of Bispecific Antibodies

Roland E. Kontermann, PhD, Professor, Institute of Cell Biology and Immunology, Stuttgart Research Center Systems Biology, University of Stuttgart
Oliver Seifert, PhD, Senior Scientist, Institute of Cell Biology and Immunology, University of Stuttgart

MONDAY, AUGUST 24 | 3:30 – 6:30 PM

SC2: Developability and Manufacturing Considerations for Bispecific Antibodies

Matthew Aspelund, PhD, Scientist II, Purification Process Sciences, AstraZeneca
Neil Mody, MSc, Scientist II, Early Stage Formulation Sciences, Dosage Form Design and Development (DFDD), AstraZeneca
Chunlei Wang, PhD, Senior Scientist, Analytical Sciences, AstraZeneca